loadpatents
name:-0.015124082565308
name:-0.012087106704712
name:-0.006187915802002
BEHAR; Vered Patent Filings

BEHAR; Vered

Patent Applications and Registrations

Patent applications and USPTO patent grants for BEHAR; Vered.The latest application filed is for "use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (hk2)-expressing cancers".

Company Profile
4.10.13
  • BEHAR; Vered - Bet Zayit IL
  • Behar; Vered - Moshav Bet Zayit IL
  • Behar; Vered - Bait Zait IL
  • Behar; Vered - Moshav Bait Zait IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Hexokinase 2/mitochondria-detaching Compounds For Treating Hexokinase-2 (hk2)-expressing Cancers
App 20220143004 - BEHAR; Vered ;   et al.
2022-05-12
Piperazine Derivatives, Pharmaceutical Compositions And Methods Of Use Thereof
App 20220098179 - Salama; Paul ;   et al.
2022-03-31
Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers
Grant 11,266,639 - Behar , et al. March 8, 2
2022-03-08
Use Of Hexokinase 2/mitochondria-detaching Compounds For Activating Immune Responses
App 20210369697 - BEHAR; Vered ;   et al.
2021-12-02
Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
Grant 11,096,935 - Behar , et al. August 24, 2
2021-08-24
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
Grant 11,084,807 - Salama , et al. August 10, 2
2021-08-10
Use Of Hexokinase 2/mitochondria-detaching Compounds For Activating Immune Responses
App 20200188381 - BEHAR; Vered ;   et al.
2020-06-18
Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
Grant 10,682,346 - Behar , et al.
2020-06-16
Piperazine Derivatives, Pharmaceutical Compositions And Methods Of Use Thereof
App 20200031815 - SALAMA; Paul ;   et al.
2020-01-30
Use Of Hexokinase 2/mitochondria-detaching Compounds For Activating Immune Responses
App 20180303819 - BEHAR; Vered ;   et al.
2018-10-25
Use Of Hexokinase 2/mitochondria-detaching Compounds For Treating Hexokinase-2 (hk2)-expressing Cancers
App 20180303820 - BEHAR; Vered ;   et al.
2018-10-25
Compositions and methods for modulating a kinase
Grant 8,937,065 - Becker , et al. January 20, 2
2015-01-20
Sulfonamides for the modulation of PKM2
Grant 8,692,001 - Becker , et al. April 8, 2
2014-04-08
Compositions and Methods for Modulating a Kinase
App 20120316148 - Becker; Oren M. ;   et al.
2012-12-13
Pyrazolines for the Modulation of PKM2
App 20120302609 - Becker; Oren M. ;   et al.
2012-11-29
Sulfonamides for the Modulation of PKM2
App 20120108631 - Becker; Oren M. ;   et al.
2012-05-03
Methods for SEM inspection of fluid containing samples
Grant 7,573,031 - Behar , et al. August 11, 2
2009-08-11
Device and method for analysis of a metabolic malady
App 20070275425 - Zik; Ory ;   et al.
2007-11-29
Methods for SEM inspection of fluid containing samples
App 20070210253 - Behar; Vered ;   et al.
2007-09-13
Methods for SEM inspection of fluid containing samples
Grant 7,230,242 - Behar , et al. June 12, 2
2007-06-12
Methods for sem inspection of fluid containing samples
App 20050173632 - Behar, Vered ;   et al.
2005-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed